Scarica l'app Stockscreener
5.03
2.72%
-0.12
Precedente Chiudi:
$5.15
Aprire:
$5.13
Volume 24 ore:
17,461
Relative Volume:
0.64
Capitalizzazione di mercato:
$9.58M
Reddito:
$7.88M
Utile/perdita netta:
$-69.20M
Rapporto P/E:
-2.7486
EPS:
-1.83
Flusso di cassa netto:
$-69.73M
1 W Prestazione:
-11.07%
1M Prestazione:
-9.40%
6M Prestazione:
-49.01%
1 anno Prestazione:
-63.90%
Intervallo 1D:
$4.97
$5.17
Intervallo di 1 settimana:
$4.97
$5.9771
Portata 52W:
$4.97
$14.36
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Nome
Bolt Biotherapeutics Inc
Settore
Industria
Telefono
650-665-9295
Indirizzo
900 CHESAPEAKE DRIVE, REDWOOD CITY
Confronta BOLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.9976 | 9.87M | 7.88M | -69.20M | -69.73M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.64 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.30 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.60 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.26 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
323.47 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Iniziato | Guggenheim | Buy |
| 2021-03-02 | Iniziato | Morgan Stanley | Overweight |
| 2021-03-02 | Iniziato | SVB Leerink | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
Bolt Biotherapeutics Inc Borsa (BOLT) Ultime notizie
Evaluating Bolt Biotherapeutics Inc. with trendline analysisOil Prices & AI Optimized Trading Strategy Guides - Newser
Trend analysis for Bolt Biotherapeutics Inc. this weekPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser
What MACD signals say about Bolt Biotherapeutics Inc.Bull Run & Weekly High Momentum Picks - Newser
Will breakout in Bolt Biotherapeutics Inc. lead to full recoveryMarket Performance Report & Verified Momentum Watchlists - Newser
Best data tools to analyze Bolt Biotherapeutics Inc. stock2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Using economic indicators to assess Bolt Biotherapeutics Inc. potential2025 Top Gainers & Daily Volume Surge Signals - Newser
Will Bolt Biotherapeutics Inc. bounce back from current supportWeekly Risk Summary & Weekly Momentum Picks - Newser
Long term hold vs stop loss in Bolt Biotherapeutics Inc.Gap Up & Stepwise Entry and Exit Trade Signals - Newser
Bolt Biotherapeutics (NASDAQ:BOLT) Stock Price Expected to Rise, Lake Street Capital Analyst Says - Defense World
Is Bolt Biotherapeutics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Report & Verified High Yield Trade Plans - Newser
Short interest data insights for Bolt Biotherapeutics Inc.July 2025 Recap & Expert Curated Trade Ideas - Newser
Multi asset correlation models including Bolt Biotherapeutics Inc.July 2025 Catalysts & Weekly High Momentum Picks - Newser
Can technical indicators confirm Bolt Biotherapeutics Inc.’s reversal2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Can momentum traders help lift Bolt Biotherapeutics Inc.July 2025 Highlights & Free Verified High Yield Trade Plans - Newser
Bolt Biotherapeutics 2025 Q2 Earnings 59.6% Reduction in Net Loss - AInvest
Intraday pattern recognizer results for Bolt Biotherapeutics Inc.2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Heatmap analysis for Bolt Biotherapeutics Inc. and competitors2025 Price Action Summary & High Return Trade Guides - Newser
Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot - Norwalk Hour
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates - ca.finance.yahoo.com
Bolt Biotherapeutics: A Case Study in Operational Efficiency and Revenue Upside in Early-Stage Biotech - AInvest
Bolt Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Bolt Bio's New Cancer Drug Enters Clinical Trials as Company Extends Cash Runway Through 2026 - Stock Titan
Key metrics from Bolt Biotherapeutics Inc.’s quarterly data2025 Performance Recap & Entry Point Strategy Guides - Newser
Will earnings trigger a reversal in Bolt Biotherapeutics Inc.M&A Rumor & Long-Term Safe Return Strategies - Newser
Is Bolt Biotherapeutics Inc. forming a bottoming basePortfolio Value Report & Risk Controlled Swing Alerts - Newser
Predicting Bolt Biotherapeutics Inc. trend using moving averagesFree Short Term Buy List With Stop Protection - Newser
Why Bolt Biotherapeutics Inc. stock attracts strong analyst attentionVolume Based Swing Signal Prediction Map - Newser
Bolt Biotherapeutics (BOLT) Expected to Announce Earnings on Tuesday - Defense World
Bolt Biotherapeutics Inc Azioni (BOLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):